11 research outputs found

    Additional file 2: Figure S2. of Endothelial differentiation of bone marrow mesenchyme stem cells applicable to hypoxia and increased migration through Akt and NFĂŽĹźB signals

    No full text
    showing the hypoxia incubator has similar gene expression patterns in both MSCs and eELCs as compared withto these observed in DFO treatments (A). Same induction effects of p-Akt in hypoxic MSCs and increase of CXCR4 in eELCs were confirmed when incubating the cells in a low oxygen incubator (B). (PDF 237 kb

    Associations of CPT values between distal extremities and bladder mucosa among diabetic women with UBD were examined by Pearson’s correlation analyses.

    No full text
    <p>(a) The 5 Hz CPT test values at the big toe were significantly associated with the 5 Hz CPT test values of bladder mucosa.(p<0.001) (b) No significant association between big toe and bladder mucosa at 250 Hz CPT values. (c) Significant association of 5 Hz CPT values between middle finger and bladder mucosa. (p<0.001) (d) No significant association noted at 250 Hz CPT values between middle finger and bladder mucosa.</p

    The effects of intravesical liposome administration on the response to acidic ATP solution stimulation in the bladder of controls and FFRs.

    No full text
    <p>Representative traces of bladder responses to acidic ATP solution instillation before and after intravesical liposome administration in the control (A), FFRs with NDF (B), and FFRs with DO (C). (D): Protective effects of liposomes on the reduction of ICI during ATP solution stimulation among groups. An asterisk indicates a significant difference between before and after intravesical liposome administration in the same group. (Paired t-test, p<0.05).</p

    Alterations of receptor protein expression in the mucosa layer or smooth muscle layer of the bladder in controls and FFRs.

    No full text
    <p>Western blot analysis with specific antibodies to the TRPV1 receptor, purinergic P2X<sub>2</sub> receptor, and P2X<sub>3</sub> receptor of the rat mucosal layer and the purinergic P2X<sub>1</sub> receptor of the rat smooth muscle layer in controls and FFRs with different in cystometric presentations. A. TRPV1 receptor: The TRPV1 antibody produced a clear single band at 95kDa. B. Purinergic P2X<sub>2</sub> receptor C. Purinergic P2X<sub>3</sub> mature receptor: the predominant P2X<sub>3</sub> form (65kDa). D. Up-regulation of P2X3 native and intermediate polypeptides (up to 55kD) were shown in both FFR groups. E. Purinergic P2X<sub>1</sub> receptor Experiments were repeated two times and representative blots are shown. Data of proteins expression (ratios of signal intensities of investigated receptors relative to β-actin or GAPDH) were calculated with 8 samples in each group. These data of Mean ± SE were standardized and expressed in percentage in which the value of the control group is treated as 100%. Theses values were shown in the bar graph. An asterisk indicates a significant difference between controls and FFR groups (One-way ANOVA with Dunnett’s test, p<0.05).</p

    Comparisons of general characteristics, biochemistry variables, and cystometric parameters among controls and FFRs.

    No full text
    <p>Data presented as mean ± SEM and tested among groups using one-way ANOVA with Dunnett’s test.</p>*<p>The Dunnett’s test showed a significant difference between the control group and other groups.</p>†<p>Homeostasis model assessment of insulin resistance (HOMA-IR) = fasting plasma insulin (µ U/ml)×fasting plasma glucose (mmol/l)/22.5.</p

    The effects of PPADS intravenous injection on the response to acidic ATP solution in the bladder of controls and FFRs.

    No full text
    <p>Representative traces of bladder responses to acidic ATP solution instillation before and after intravenous PPADS administration in the control (A), FFRs with NDF (B), and FFRs with DO (C). (D): Purinergic antagonist effects of PPADS on the reduction of ICI during ATP solution stimulation among groups. An asterisk indicates a significant difference between before and after intravenous PPADS administration in the same group. (Paired t- test, p<0.05).</p
    corecore